Form 4: Amphastar Pharmaceuticals Director Michael Zasloff Sells Shares

Director Michael Zasloff of Amphastar Pharmaceuticals sold a total of 12,500 shares of common stock on March 5, 2024, in two separate transactions.

Summary

• On March 5, 2024, Michael Zasloff, a director of Amphastar Pharmaceuticals, sold 9,389 shares of common stock at a weighted average price of $47.0626.
• He also sold 3,111 shares of common stock at a weighted average price of $47.526 on the same day.
• Following these transactions, Zasloff directly owns 21,326 shares of Amphastar Pharmaceuticals.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock sales by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider transactions.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a publicly traded company buy or sell the company's securities. These filings provide transparency into the transactions of company directors and officers.

Stakeholder Impact

• The stock sale by a director could be perceived differently by stakeholders; some may see it as a lack of confidence, while others may view it as a personal financial decision.

Key Dates